Literature DB >> 31328102

Magnetic resonance imaging for invasive lobular carcinoma: is it worth it?

Sarah Jayne Barker1, Eileen Anderson1, Russell Mullen1.   

Abstract

BACKGROUND: Invasive lobular cancer (ILC) of the breast can provide diagnostic and therapeutic challenges due to its often mammographically occult and multifocal nature. UK guidelines recommend magnetic resonance imaging (MRI) when considering breast conserving surgery (BCS) in women with a diagnosis of ILC. A small number of studies have shown that due to its low specificity, MRI can lead to additional invasive investigations whilst rarely identifying additional tumour foci that affect management. We carried out a retrospective study of patients diagnosed with ILC to assess the impact of MRI on management and to evaluate if breast density on mammography could indicate likelihood of additional disease being found on MRI.
METHODS: A retrospective analysis of the electronic patient records for all cases of ILC diagnosed between January 2013 and December 2016 was carried out.
RESULTS: A total of 110 cases of ILC were identified of which 69 women were considered for BCS and 58 (84.1%) women underwent MRI. A further abnormality was seen in 22 (37.9%) patients of whom 13 (59.1%) had a further core biopsy with 4 cases being positive for malignancy. Overall MRI changed the surgical plan from BCS to mastectomy in 7 (10.1%). Breast density did not predict the presence of additional findings on MRI.
CONCLUSIONS: MRI assessment of ILC rarely affects the management when BCS is considered. Having radiologically denser breasts did not correlate with increased reoperation rate. Larger prospective studies may provide further guidance on MRI specificity and breast density.

Entities:  

Keywords:  Invasive lobular carcinoma (ILC); breast cancer; magnetic resonance imaging (MRI)

Year:  2019        PMID: 31328102      PMCID: PMC6606482          DOI: 10.21037/gs.2018.10.04

Source DB:  PubMed          Journal:  Gland Surg        ISSN: 2227-684X


  16 in total

1.  American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography.

Authors:  Debbie Saslow; Carla Boetes; Wylie Burke; Steven Harms; Martin O Leach; Constance D Lehman; Elizabeth Morris; Etta Pisano; Mitchell Schnall; Stephen Sener; Robert A Smith; Ellen Warner; Martin Yaffe; Kimberly S Andrews; Christy A Russell
Journal:  CA Cancer J Clin       Date:  2007 Mar-Apr       Impact factor: 508.702

Review 2.  Review of preoperative magnetic resonance imaging (MRI) in breast cancer: should MRI be performed on all women with newly diagnosed, early stage breast cancer?

Authors:  Nehmat Houssami; Daniel F Hayes
Journal:  CA Cancer J Clin       Date:  2009-08-13       Impact factor: 508.702

3.  Preoperative MRI and surgical management in patients with nonpalpable breast cancer: the MONET - randomised controlled trial.

Authors:  N H G M Peters; S van Esser; M A A J van den Bosch; R K Storm; P W Plaisier; T van Dalen; S C E Diepstraten; T Weits; P J Westenend; G Stapper; M A Fernandez-Gallardo; I H M Borel Rinkes; R van Hillegersberg; W P Th M Mali; P H M Peeters
Journal:  Eur J Cancer       Date:  2010-12-30       Impact factor: 9.162

4.  Comparative effectiveness of MRI in breast cancer (COMICE) trial: a randomised controlled trial.

Authors:  Lindsay Turnbull; Sarah Brown; Ian Harvey; Catherine Olivier; Phil Drew; Vicky Napp; Andrew Hanby; Julia Brown
Journal:  Lancet       Date:  2010-02-13       Impact factor: 79.321

5.  Diagnostic accuracy of mammography, clinical examination, US, and MR imaging in preoperative assessment of breast cancer.

Authors:  Wendie A Berg; Lorena Gutierrez; Moriel S NessAiver; W Bradford Carter; Mythreyi Bhargavan; Rebecca S Lewis; Olga B Ioffe
Journal:  Radiology       Date:  2004-10-14       Impact factor: 11.105

6.  Magnetic resonance imaging in the planning of initial lumpectomy for invasive breast carcinoma: its effect on ipsilateral breast tumor recurrence after breast-conservation therapy.

Authors:  Nicholas Hwang; Dan E Schiller; Pavel Crystal; Ellen Maki; David R McCready
Journal:  Ann Surg Oncol       Date:  2009-07-15       Impact factor: 5.344

7.  The impact of preoperative breast MRI on the re-excision rate in invasive lobular carcinoma of the breast.

Authors:  R M Mann; C E Loo; T Wobbes; P Bult; J O Barentsz; K G A Gilhuijs; C Boetes
Journal:  Breast Cancer Res Treat       Date:  2010-01       Impact factor: 4.872

8.  Association of routine pretreatment magnetic resonance imaging with time to surgery, mastectomy rate, and margin status.

Authors:  Richard J Bleicher; Robin M Ciocca; Brian L Egleston; Linda Sesa; Kathryn Evers; Elin R Sigurdson; Monica Morrow
Journal:  J Am Coll Surg       Date:  2009-06-18       Impact factor: 6.113

Review 9.  Accuracy and surgical impact of magnetic resonance imaging in breast cancer staging: systematic review and meta-analysis in detection of multifocal and multicentric cancer.

Authors:  Nehmat Houssami; Stefano Ciatto; Petra Macaskill; Sarah J Lord; Ruth M Warren; J Michael Dixon; Les Irwig
Journal:  J Clin Oncol       Date:  2008-05-12       Impact factor: 44.544

10.  Breast MRI: guidelines from the European Society of Breast Imaging.

Authors:  R M Mann; C K Kuhl; K Kinkel; C Boetes
Journal:  Eur Radiol       Date:  2008-04-04       Impact factor: 5.315

View more
  1 in total

1.  Multimodality imaging in lobular breast cancer: Differences in mammography, ultrasound, and MRI in the assessment of local tumor extent and correlation with molecular characteristics.

Authors:  Bartosz Dołęga-Kozierowski; Michał Lis; Hanna Marszalska-Jacak; Mateusz Koziej; Marcin Celer; Małgorzata Bandyk; Piotr Kasprzak; Bartłomiej Szynglarewicz; Rafał Matkowski
Journal:  Front Oncol       Date:  2022-08-22       Impact factor: 5.738

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.